These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8560578)
21. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. Johnson BD; Becker EE; LaBelle JL; Truitt RL J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039 [TBL] [Abstract][Full Text] [Related]
22. Migration and activation of T cells during development of graft-versus-host disease in a mouse model. Wen HS; Wang JM; Zhou H; Gong SI; Gao L; Wu Y Transplant Proc; 2013 Mar; 45(2):713-8. PubMed ID: 23498811 [TBL] [Abstract][Full Text] [Related]
23. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions. Mutis T; Aarts-Riemens T; Verdonck LF Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576 [TBL] [Abstract][Full Text] [Related]
24. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519 [TBL] [Abstract][Full Text] [Related]
25. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613 [TBL] [Abstract][Full Text] [Related]
26. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. Zeng D; Lewis D; Dejbakhsh-Jones S; Lan F; García-Ojeda M; Sibley R; Strober S J Exp Med; 1999 Apr; 189(7):1073-81. PubMed ID: 10190898 [TBL] [Abstract][Full Text] [Related]
27. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses. Korngold R Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163 [TBL] [Abstract][Full Text] [Related]
28. Poly dispersed acid-functionalized single walled carbon nanotubes target activated T and B cells to suppress acute and chronic GVHD in mouse model. Mia MB; Saxena RK Immunol Lett; 2020 Aug; 224():30-37. PubMed ID: 32504776 [TBL] [Abstract][Full Text] [Related]
29. IL-18 prevents the development of chronic graft-versus-host disease in mice. Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292 [TBL] [Abstract][Full Text] [Related]
30. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression. Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571 [TBL] [Abstract][Full Text] [Related]
31. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation. Miconnet I; de La Selle V; Bruley-Rosset M Bone Marrow Transplant; 1998 Mar; 21(6):583-90. PubMed ID: 9543062 [TBL] [Abstract][Full Text] [Related]
32. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. Gendelman M; Hecht T; Logan B; Vodanovic-Jankovic S; Komorowski R; Drobyski WR J Immunol; 2004 Mar; 172(5):3328-36. PubMed ID: 14978141 [TBL] [Abstract][Full Text] [Related]
33. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model. Nguyen V; Rus H; Chen C; Rus V J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801 [TBL] [Abstract][Full Text] [Related]
34. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015 [TBL] [Abstract][Full Text] [Related]
35. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383 [TBL] [Abstract][Full Text] [Related]
36. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148 [TBL] [Abstract][Full Text] [Related]
37. Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells. Anderson BE; Taylor PA; McNiff JM; Jain D; Demetris AJ; Panoskaltsis-Mortari A; Ager A; Blazar BR; Shlomchik WD; Shlomchik MJ Blood; 2008 May; 111(10):5242-51. PubMed ID: 18285547 [TBL] [Abstract][Full Text] [Related]
38. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells. Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625 [TBL] [Abstract][Full Text] [Related]
39. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice. Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409 [TBL] [Abstract][Full Text] [Related]
40. Contributions of donor CD4 and CD8 cells to liver injury during murine graft-versus-host disease. Li J; Helm K; Howell CD Transplantation; 1996 Dec; 62(11):1621-8. PubMed ID: 8970618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]